NanoActive r-RETINOATE

NanoActive r-RETINOATE

8× retinol activity

Photostable • Non-irritating

A next-generation vitamin A derivative

Company Overview

PuriPharm Biopharmaceutical Technology Co., Ltd.

Delivering Beauty • Creating Value

Focused on the research and development of bioactives.

  • Specialized in the development of bioactive materials and functional ingredient systems.
  • Combines scientific delivery technology with application-oriented product design.
  • Dedicated to high-performance ingredients for beauty and personal care.

Nano Delivery Technology

  • One of the most widely studied and applied new formulation technologies.
  • Applicable across pharmaceuticals, foods, cosmetics and other fields.
  • Nano-bioactives are new products developed using nanodelivery systems.
  • Improves solubility, stability, irritation profile and odor while offering unique biological effects.

Fourth-Generation (4G) Cosmetic Ingredients

  • Clearly defined ingredients and content
  • Clearly defined targets
  • Clear mechanism of action
  • Formulations designed to preserve bioactivity
  • Good solubility
  • Stable and non-discoloring
  • Easy to absorb

A perfect combination of traditional medicine, modern biotechnology and nanotechnology.

Unique Occlusion Effect

Follicular Targeted Absorption

  • Nanocarriers accumulate efficiently around the hair follicle pathway.
  • This supports targeted delivery into deep skin appendages where actives can be retained and released.

Key takeaway:Hair follicles provide an efficient access route for targeted nano-delivery.

Smaller Particles Penetrate Deeper

and in Greater Amounts

  • Reduced particle size increases penetration depth in skin.
  • Smaller particles also increase the delivered amount of active ingredient.

The smaller the carrier, the deeper the penetration and the higher the delivery amount.

Follicular Reservoir Enables Slow Release for

More Than 10 Days

  • Hair follicles act as a storage reservoir for the active ingredient.
  • The active can be released gradually for more than 10 days after deposition.
  • This supports long-lasting efficacy with sustained local availability.

Long-lasting delivery:Slow release extends the activity window after follicular deposition.

Vitamin A:

A core scientific foundation for the product story

Functions of Vitamin A in the Human Body

  • Supports vision and visual signaling.
  • Contributes to growth, reproduction and immune support.
  • Involved in antioxidant defense, cell differentiation and gene transcription.

Vitamin A and Nobel Prizes

Vitamin A Is the Gold Standard in Anti-Aging Skincare

Common Vitamin A Actives Used in Skincare

Conversion to Retinoic Acid in Vivo

Why It Won the Award

2019 Ringier Technology Innovation Award

  • Vitamin A derivative suitable for daytime use
  • Safe and low irritation
  • Nano-encapsulation protects the active ingredient
  • A breakthrough and a new technical approach for retinoid raw materials

A distinctive retinoid concept that balances efficacy, stability and tolerability.

Unique Absorption Spectrum

  • Distinctive absorption profile
  • Efficient blue-light absorption
  • Good photostability

Product Introduction

  • Retinyl retinoate is obtained by esterifying the hydroxyl group of retinol with retinoic acid, while avoiding the application limits of retinol and retinoic acid in cosmetics.
  • NanoActive r-RETINOATE has an encapsulated particle size of 20–30 nm. This nanoemulsion size keeps the active stably suspended in the nanocarrier, enhances skin penetration and helps control the release rate.

Particle size:20–30 nm nano-encapsulation;

Delivery effect:Stable suspension, enhanced penetration and controlled release

Product Introduction

Skincare Benefits of Retinyl Retinoate

Efficacy Summary

Product Description

Formulation Guide

Suitable Products

Anti-aging products:

Maintains collagen in the dermis and helps prevent excessive collagen degradation.

When combined with hyaluronic acid and biocomposite polysaccharides (hydrolyzed myrtle), improvement in fine lines can be observed within one week.

Brightening products:

Works synergistically with vitamin C to inhibit tyrosinase, promote metabolism and accelerate fading of melanin.

The source deck notes that pairing with vitamin C is also effective for acne-prone skin.

Suitable Products

Sunscreen products:

Inhibits the UV-induced increase of MMP activity and helps protect elastic fibers and dermal collagen.

Improves wrinkles and fine lines caused by UV exposure.

Repair products:

Promotes endogenous hyaluronic acid synthesis and reduces skin TEWL.

Promotes keratinocyte activity and increases epidermal thickness, making the epidermis stronger.

NanoActive® 7-DHC THE SKIN-NATIVE PROVITAMIN D PLATFORM

Executive Overview
Science-Backed Innovation
PuriPharmis a leading specialist in the design and manufacture of high-functional cosmetic active ingredients and advanced delivery platforms.
Our mission is to empower global B2B customers with biologically meaningful solutions that translate complex cellular science into commercially successful skincare products.
PuriPharmBrand Framework
Why 7-DHC Matters
Endogenous Relevance
7-dehydrocholesterol (7-DHC) is a skin-native precursor produced naturally in the human epidermis.
As a key intermediate in the cholesterol biosynthetic pathway, it represents a truebiomimeticapproach to skin health, aligning with the skin’s inherent chemistry.
 
The Provitamin D Pathway
Homeostatic Skin Support
Translating Science to Beauty
The Delivery Advantage
The 7-DHC Innovation Platform
Beyond Traditional Actives
NanoActive® 7-DHC represents more than an ingredient—it is abiological platformfor brands seeking the next frontier in skin resilience.
By mimicking endogenous pathways, it offers a “Biology-First” marketing angle that resonates with sophisticated, research-driven consumers.
Mechanism of Action
Evidence Hierarchy
Polished Claim Map
Formulation Guidelines
Concept Applications
Target Consumer Needs
 
The Differentiation Edge
Commercial Strategic Value
Key Takeaways
 

Retinal (Retinaldehyde) Market Outlook & Strategic Analysis Report

I. Background:

The “EU Vitamin A Restriction” Shaking the Industry

The formal implementation of Regulation (EU) 2024/996 marks a pivotal regulatory turning point for Vitamin A derivatives in the skincare industry.

1. Key Regulatory Highlights

  • Concentration Thresholds: From November 1, 2025, new face and leave-on products must not exceed 0.3% Retinol Equivalent (RE); body lotions are limited to 0.05% RE.
  • Grace Period: Non-compliant products already on the market must be withdrawn by May 1, 2027.
  • Mandatory Labeling: Products must include a warning: “Contains Vitamin A. Consider your daily intake before use.”

2. Industry Ripple Effects

This regulation forces a paradigm shift from “High Concentration” to “High Efficiency.” Retinal (Retinaldehyde), the direct precursor to Retinoic Acid, has emerged as the premier alternative to Retinol, offering superior performance within the new legal limits.

II. Core Value:

Why Retinal is the “Optimal Solution”

Under the 0.3% concentration cap, Retinal provides a much higher “performance ceiling” compared to Retinol.

  • Conversion Efficiency: Retinal requires only one conversion step to become Retinoic Acid (the active form), whereas Retinol requires two. Research indicates Retinal’s bio-activity is approximately 10-11 times more efficient than Retinol.
  • Compliance Advantage: At the 0.3% EU limit, Retinal can deliver anti-aging results comparable to unregulated high-concentration Retinol (1.0%+) products of the past.
  • Antibacterial Benefits: Unlike Retinol, Retinal possesses natural antimicrobial activity, making it a unique solution for the “adult acne & anti-aging” dual-segment.

III. Technical Strategy:

Advanced Delivery & Synergistic Formulas

To overcome Retinal’s inherent instability, the following next-generation combinations are recommended:

1. Retinal + Silybin (Phyto-Retinol Strategy):

  • Silybin is highlighted as the premier plant-based Retinol alternative. It promotes collagen regeneration via “Retinoid-like” pathways without the irritation.
  • Its potent anti-inflammatory properties significantly down-regulate pro-inflammatory cytokines, mitigating the potential irritation often associated with Retinal.

2. Retinal + Hexylresorcinol (Multi-Target Aging):

  • Hexylresorcinol inhibits melanin synthesis while reinforcing the dermal support structure.
  • This synergy achieves a “1+1>2” effect for intensive wrinkle reduction and skin tone brightening.

IV. Core Competitive Advantages of PuriPharm

As a leader in Nano-Delivery Systems (NDS), PuriPharm is uniquely positioned to solve the stability and penetration challenges of Retinal:

1. Pharmaceutical-Grade Nano-Encapsulation (NanoActive®)

  • Solving Stability Issues: Retinal is extremely sensitive to light and oxygen. PuriPharm’s Nano-Liposome technology isolates the active from environmental factors, ensuring long-term potency.
  • Enhanced Skin Penetration: With particle sizes typically below 30nm, NanoActive® RAL (Retinal) penetrates the skin barrier more effectively than traditional formulations, reaching the deeper dermis.
  • Reduced Irritation (De-noising): Controlled release technology ensures a steady delivery of actives, minimizing the “Retinoid reaction” (redness and peeling).

2. Comprehensive Synergistic Ingredient Portfolio

PuriPharm provides a complete suite of nano-encapsulated actives, including NanoActive® RAL, NanoActive® Silybin, and NanoActive® Hexylresorcinol.

Universal Nano-Compatibility allows formulators to combine these “Triple Threat” ingredients seamlessly, ensuring physical stability and a premium, non-greasy skin feel.

3. Professional R&D & Data Support

  • Backed by a founding team with deep pharmaceutical backgrounds, PuriPharm provides robust in-vitro and clinical efficacy data. This assists global brands in justifying their claims and navigating strict EU labeling requirements.

V. Strategic Opportunities for the International Market

  1. Concentration-to-Efficiency Rebranding: Help brands leverage 0.3% Retinal Nano-products to outperform 1.0% Retinol competitors in efficacy.
  2. Global Compliance Transition: Provide ready-to-use, EU-compliant ingredient solutions and stability dossiers for brands looking to enter or stay in the European market.
  3. Custom NDS Development: Utilize the NDS platform to create exclusive “Retinal + X” nano-complexes, building a proprietary technical moat for the brand.

VI. Conclusion

The EU Vitamin A restriction is not an end, but the beginning of the “Era of Scientific Anti-Aging.” By utilizing PuriPharm’s Nano-Delivery Systems to master the stability and delivery of Retinal, brands can achieve market dominance in the post-retinol landscape.

Bioactive HD 100

Hexamidine diisethionate;HD-100;BioActive HD 100;Elestab HP 100.

anti-dandruff; anti-acne; anti-dermatitis; deodorizing; stratum corneum repair; skin anti-aging.

CAS: 659-40-5.

Continue reading